Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Four drug metabolism-related subgroups of pancreatic adenocarcinoma in prognosis, immune infiltration, and gene mutation. | Open Med (Wars) | 2022 | 35340619 | PubTator, text mining | PubMed |
| On the Origin and Propagation of the COVID-19 Outbreak in the Italian Province of Trento, a Tourist Region of Northern Italy. | Viruses | 2022 | 35336987 | PubTator, text mining | PubMed |
| Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications. | Int J Mol Sci | 2022 | 35328726 | PubTator, text mining | PubMed |
| Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics. | Genes (Basel) | 2022 | 35327979 | PubTator, text mining | PubMed |
Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8+ T Cells in Immunotherapy-Resistant and Metastatic Cancers. | Cancers (Basel) | 2022 | 35326747 | PubTator, text mining | PubMed |
| Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse. | Medicines (Basel) | 2022 | 35323718 | PubTator, text mining | PubMed |
| Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1. | Am J Kidney Dis | 2022 | 35306035 | PubTator, text mining | PubMed |
| Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections. | J Allergy Clin Immunol | 2022 | 35304160 | PubTator, text mining | PubMed |
| Insights Into the Peroxisomal Protein Inventory of Zebrafish. | Front Physiol | 2022 | 35295584 | PubTator, text mining | PubMed |
| Natural 5-Aminolevulinic Acid: Sources, Biosynthesis, Detection and Applications. | Front Bioeng Biotechnol | 2022 | 35284403 | PubTator, text mining | PubMed |
| Current Advances in RNA Therapeutics for Human Diseases. | Int J Mol Sci | 2022 | 35269876 | PubTator, text mining | PubMed |
| Molecular Cytogenetic Characterization of Novel 1RS.1BL Translocation and Complex Chromosome Translocation Lines with Stripe Rust Resistance. | Int J Mol Sci | 2022 | 35269872 | PubTator, text mining | PubMed |
| Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease. | Int J Mol Sci | 2022 | 35269861 | PubTator, text mining | PubMed |
| Molecular Mechanism of Lipotoxicity as an Interesting Aspect in the Development of Pathological States-Current View of Knowledge. | Cells | 2022 | 35269467 | PubTator, text mining | PubMed |
| New therapeutics for primary hyperoxaluria type 1. | Curr Opin Nephrol Hypertens | 2022 | 35266883 | PubTator, text mining | PubMed |
| Characterisation of breast cancer molecular signature and treatment assessment with vibrational spectroscopy and chemometric approach. | PLoS One | 2022 | 35263369 | PubTator, text mining | PubMed |
| Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1. | Kidney Int Rep | 2022 | 35257062 | PubTator, text mining | PubMed |
| RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition. | Clin Cancer Res | 2022 | 35247929 | PubTator, text mining | PubMed |
| Infantile Primary Hyperoxaluria Type 1 Treated With Lumasiran in Twin Males. | Cureus | 2022 | 35237473 | PubTator, text mining | PubMed |
| ADAP1 promotes latent HIV-1 reactivation by selectively tuning KRAS-ERK-AP-1 T cell signaling-transcriptional axis. | Nat Commun | 2022 | 35232997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=40